Theoharides, Theoharis C., et al
loved it I seen results and my energy has improved Kim Fast shipping & such an easy convenience
Research published in obesity and metabolic journals has documented that patients on GLP-1 therapies sometimes report reduced anxiety alongside weight loss
GLP-1 agonists and tirzepatide may cause unpleasant side effects including dizziness, headache, indigestion or upset stomach, nausea, vomiting, diarrhoea and feeling jittery
It was developed in the early 1990s by the Danish pharmaceutical company Novo Nordisk, who were looking for a long-acting yet therapeutically effective treatment of type 2 diabetes [1]
For more information on womens health, visit our dedicated section